Literature DB >> 21056986

Biochemical and morphological properties of hepatitis C virus particles and determination of their lipidome.

Andreas Merz1, Gang Long, Marie-Sophie Hiet, Britta Brügger, Petr Chlanda, Patrice Andre, Felix Wieland, Jacomine Krijnse-Locker, Ralf Bartenschlager.   

Abstract

A hallmark of hepatitis C virus (HCV) particles is their association with host cell lipids, most notably lipoprotein components. It is thought that this property accounts for the low density of virus particles and their large heterogeneity. However, the composition of infectious virions and their biochemical and morphological properties are largely unknown. We developed a system in which the envelope glycoprotein E2 was N-terminally tagged with a FLAG epitope. This virus, designated Jc1E2(FLAG), produced infectivity titers to wild type levels and allowed affinity purification of virus particles that were analyzed for their protein and lipid composition. By using mass spectrometry, we found the lipid composition of Jc1E2(FLAG) particles to resemble the one very low- and low density-lipoprotein with cholesteryl esters accounting for almost half of the total HCV lipids. Thus, HCV particles possess a unique lipid composition that is very distinct from all other viruses analyzed so far and from the human liver cells in which HCV was produced. By electron microscopy (EM), we found purified Jc1E2(FLAG) particles to be heterogeneous, mostly spherical structures, with an average diameter of about 73 nm. Importantly, the majority of E2-containing particles also contained apoE on their surface as assessed by immuno-EM. Taken together, we describe a rapid and efficient system for the production of large quantities of affinity-purified HCV allowing a comprehensive analysis of the infectious virion, including the determination of its lipid composition.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21056986      PMCID: PMC3024796          DOI: 10.1074/jbc.M110.175018

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  74 in total

1.  Quantitative determination of phospholipid compositions by ESI-MS: effects of acyl chain length, unsaturation, and lipid concentration on instrument response.

Authors:  M Koivusalo; P Haimi; L Heikinheimo; R Kostiainen; P Somerharju
Journal:  J Lipid Res       Date:  2001-04       Impact factor: 5.922

Review 2.  The biogenesis and functions of lipid bodies in animals, plants and microorganisms.

Authors:  D J Murphy
Journal:  Prog Lipid Res       Date:  2001-09       Impact factor: 16.195

3.  Ultrastructural and biophysical characterization of hepatitis C virus particles produced in cell culture.

Authors:  Pablo Gastaminza; Kelly A Dryden; Bryan Boyd; Malcolm R Wood; Mansun Law; Mark Yeager; Francis V Chisari
Journal:  J Virol       Date:  2010-08-04       Impact factor: 5.103

4.  Intravascular transfer contributes to postprandial increase in numbers of very-low-density hepatitis C virus particles.

Authors:  Daniel J Felmlee; David A Sheridan; Simon H Bridge; Søren U Nielsen; Ross W Milne; Chris J Packard; Muriel J Caslake; John McLauchlan; Geoffrey L Toms; R Dermot G Neely; Margaret F Bassendine
Journal:  Gastroenterology       Date:  2010-08-02       Impact factor: 22.682

5.  Apolipoprotein E participates in the regulation of very low density lipoprotein-triglyceride secretion by the liver.

Authors:  A R Mensenkamp; M C Jong; H van Goor; M J van Luyn; V Bloks; R Havinga; P J Voshol; M H Hofker; K W van Dijk; L M Havekes; F Kuipers
Journal:  J Biol Chem       Date:  1999-12-10       Impact factor: 5.157

6.  Functional analysis of hepatitis C virus E2 glycoproteins and virus-like particles reveals structural dissimilarities between different forms of E2.

Authors:  Ania Owsianka; Reginald F Clayton; Lawrence D Loomis-Price; Jane A McKeating; Arvind H Patel
Journal:  J Gen Virol       Date:  2001-08       Impact factor: 3.891

Review 7.  Assembly of infectious hepatitis C virus particles.

Authors:  Ralf Bartenschlager; Francois Penin; Volker Lohmann; Patrice André
Journal:  Trends Microbiol       Date:  2010-12-14       Impact factor: 17.079

8.  Cyclophilin A is an essential cofactor for hepatitis C virus infection and the principal mediator of cyclosporine resistance in vitro.

Authors:  Feng Yang; Jason M Robotham; Heather B Nelson; Andre Irsigler; Rachael Kenworthy; Hengli Tang
Journal:  J Virol       Date:  2008-04-02       Impact factor: 5.103

9.  Evidence for segregation of sphingomyelin and cholesterol during formation of COPI-coated vesicles.

Authors:  B Brügger; R Sandhoff; S Wegehingel; K Gorgas; J Malsam; J B Helms; W D Lehmann; W Nickel; F T Wieland
Journal:  J Cell Biol       Date:  2000-10-30       Impact factor: 10.539

10.  Secretion of hepatitis C virus envelope glycoproteins depends on assembly of apolipoprotein B positive lipoproteins.

Authors:  Vinca Icard; Olivier Diaz; Caroline Scholtes; Laure Perrin-Cocon; Christophe Ramière; Ralf Bartenschlager; Francois Penin; Vincent Lotteau; Patrice André
Journal:  PLoS One       Date:  2009-01-21       Impact factor: 3.240

View more
  165 in total

1.  CD59 incorporation protects hepatitis C virus against complement-mediated destruction.

Authors:  Tohti Amet; Marwan Ghabril; Naga Chalasani; Daniel Byrd; Ningjie Hu; Ayslinn Grantham; Ziqing Liu; Xuebin Qin; Johnny J He; Qigui Yu
Journal:  Hepatology       Date:  2011-12-16       Impact factor: 17.425

2.  Exiting from uncharted territory: hepatitis C virus assembles in mouse cell lines.

Authors:  Margaret A Scull; Alexander Ploss
Journal:  Hepatology       Date:  2012-02       Impact factor: 17.425

3.  Protein kinase D negatively regulates hepatitis C virus secretion through phosphorylation of oxysterol-binding protein and ceramide transfer protein.

Authors:  Yutaka Amako; Gulam H Syed; Aleem Siddiqui
Journal:  J Biol Chem       Date:  2011-02-01       Impact factor: 5.157

Review 4.  Unique ties between hepatitis C virus replication and intracellular lipids.

Authors:  Eva Herker; Melanie Ott
Journal:  Trends Endocrinol Metab       Date:  2011-04-15       Impact factor: 12.015

5.  Hepatitis C virus attachment mediated by apolipoprotein E binding to cell surface heparan sulfate.

Authors:  Jieyun Jiang; Wei Cun; Xianfang Wu; Qing Shi; Hengli Tang; Guangxiang Luo
Journal:  J Virol       Date:  2012-04-24       Impact factor: 5.103

6.  Hepatitis C Virus Is Released via a Noncanonical Secretory Route.

Authors:  Karen Bayer; Carina Banning; Volker Bruss; Linda Wiltzer-Bach; Michael Schindler
Journal:  J Virol       Date:  2016-11-14       Impact factor: 5.103

7.  TM6SF2 Promotes Lipidation and Secretion of Hepatitis C Virus in Infected Hepatocytes.

Authors:  Audrey Boyer; Seung Bum Park; Ynto S de Boer; Qisheng Li; T Jake Liang
Journal:  Gastroenterology       Date:  2018-08-23       Impact factor: 22.682

8.  Very-low-density lipoprotein (VLDL)-producing and hepatitis C virus-replicating HepG2 cells secrete no more lipoviroparticles than VLDL-deficient Huh7.5 cells.

Authors:  Baptiste Jammart; Maud Michelet; Eve-Isabelle Pécheur; Romain Parent; Birke Bartosch; Fabien Zoulim; David Durantel
Journal:  J Virol       Date:  2013-02-20       Impact factor: 5.103

9.  Sigma-1 receptor regulates early steps of viral RNA replication at the onset of hepatitis C virus infection.

Authors:  Martina Friesland; Lidia Mingorance; Josan Chung; Francis V Chisari; Pablo Gastaminza
Journal:  J Virol       Date:  2013-03-27       Impact factor: 5.103

10.  A molecular tweezer antagonizes seminal amyloids and HIV infection.

Authors:  Edina Lump; Laura M Castellano; Christoph Meier; Janine Seeliger; Nelli Erwin; Benjamin Sperlich; Christina M Stürzel; Shariq Usmani; Rebecca M Hammond; Jens von Einem; Gisa Gerold; Florian Kreppel; Kenny Bravo-Rodriguez; Thomas Pietschmann; Veronica M Holmes; David Palesch; Onofrio Zirafi; Drew Weissman; Andrea Sowislok; Burkhard Wettig; Christian Heid; Frank Kirchhoff; Tanja Weil; Frank-Gerrit Klärner; Thomas Schrader; Gal Bitan; Elsa Sanchez-Garcia; Roland Winter; James Shorter; Jan Münch
Journal:  Elife       Date:  2015-08-18       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.